Dr Geoffrey Dusheiko advocated for obtaining a research grant "for [the] potentially clinically beneficial undertaking" of considering the value of treatment by interferon and ribavirin.
Chronology Information
Date:
Chapter/issue
Hepatitis C Lookback
Key Person(s)
Professor G.M. Dusheiko